1. Home
  2. UG vs NRSN Comparison

UG vs NRSN Comparison

Compare UG & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$7.00

Market Cap

30.8M

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.83

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
NRSN
Founded
1942
2017
Country
United States
Israel
Employees
N/A
16
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
26.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
UG
NRSN
Price
$7.00
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
5.7K
143.3K
Earning Date
05-11-2026
03-31-2026
Dividend Yield
7.10%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$10,545,468.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
$35.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.63
52 Week High
$9.88
$2.60

Technical Indicators

Market Signals
Indicator
UG
NRSN
Relative Strength Index (RSI) 53.78 51.83
Support Level $6.31 $0.67
Resistance Level $7.70 $0.86
Average True Range (ATR) 0.30 0.06
MACD -0.01 -0.00
Stochastic Oscillator 43.59 35.02

Price Performance

Historical Comparison
UG
NRSN

About UG United-Guardian Inc.

United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: